A drug designed to fight triple negative breast cancer already shows promising results.  A new development in drug design could pave the way for a new generation of drugs that could be used to treat a range of diseases. By precisely targeting genes and sequences that allow diseases to proliferate, the researchers believe that they can stop or slow their progression to make them more manageable. {read more here}